HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Skin care trends

This article was originally published in The Rose Sheet

Executive Summary

Traditional skin care marketers are attempting to compete with dermatologist-developed skin care brands such as Dr. Perricone and Dr. Brandt by offering products with therapeutic, high-end positioning, market research firm Kline & Co. concludes in skin care study to be published this fall. Products pursuing that approach include Avon Clinical and P&G's Olay Regenerist, which are touted as advanced anti-aging offerings. Prestige marketers such as Estee Lauder also are offering more clinically-positioned skin care treatments. Lauder recently purchased dermatologist-developed Rodan & Field's skin care line, while firm's Prescriptives brand relies on spokesperson Dr. Karen Grossman to promote its Dermapolish at-home microdermabrasion system (1"The Rose Sheet" July 21, 2003, p. 9)...

You may also be interested in...



Lauder Rodan & Fields Buy Adds Dermatological Brand To Skin Care Portfolio

Estee Lauder is moving into the dermatological skin care category with the acquisition of Rodan & Fields, a product line developed by dermatologists and sold in selective high-end department stores

CSL Seeks Disruption Of HAE Space With Monthly Prevention Product

Based on top-line Phase III data for garadacimab, CSL is preparing to submit the Factor XIIa inhibitor for US FDA approval for monthly prophylaxis of hereditary angioedema and expand the firm’s HAE franchise.

Nicotine Gummies Sold For Smoking Cessation Doused Under US FDA Tobacco Regulations

FDA says warning to VPR Brands could be its first move to reign in sales of nicotine gummies. Statements on brand’s site could indicate sales of nicotine gummies for smoking cessation are on the rise even though the claim isn’t approved.

Latest News
See All
UsernamePublicRestriction

Register

RS011548

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel